{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-25-000022","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2025-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.364664+00:00","generated_at":"2026-05-25T23:36:08.077944+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keros CEO to present at TD Cowen and Leerink healthcare conferences in March","bullets":["CEO Jasbir Seehra to present at TD Cowen 45th Annual Healthcare Conference on March 3, 2025 at 9:50 a.m. ET.","CEO to present at Leerink Partners Global Healthcare Conference on March 10, 2025 at 1:40 p.m. ET.","Both presentations will be in fireside chat format with webcast links provided.","Archived replays available on Keros investor website for up to 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-25-000022","json":"https://secwatch.observer/filing/0001664710-25-000022.json","markdown":"https://secwatch.observer/filing/0001664710-25-000022.md","text":"https://secwatch.observer/filing/0001664710-25-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000022/0001664710-25-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000022/kros-20250228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T23:36:08.077944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}